People · Operator
Named in public records as an officer, director or promoter · active 2016–2017 · Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| SteadyMed Ltd. | — | Pharmaceuticals | Series B | $51.3M | $1.0B | 2016 |
Elizabeth W. Cermak at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Elizabeth W. Cermak on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Jonathan Rigby | 1 | 4 |
| David W. Nassif | 1 | 2 |
| Brian W. Stark | 1 | 1 |
| Stephen W. Farr | 1 | 1 |
| Keith W. Bank | 1 | 1 |
| Ron W. Ginor | 1 | 1 |
| Donald W. Huffman | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.